The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...
Q4 2024 Management View CEO Richard Miller detailed the progress of soquelitinib, emphasizing its potential as a first-in-class oral therapy for immune diseases and cancers. He highlighted the 39% ...
Track star and Olympian Gabby Thomas is officially engaged to her longtime boyfriend, Spencer McManes! Here’s what we know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback